The Ras protein itself has proved challenging to inhibit directly, although a very recent study reported on the development of a small molecule inhibitor, which specifically decreased viability and induced apoptosis of lung cancer cell lines expressing KRAS G12C, but had no effect on wild type cells or those bearing other KRAS mutations. This evidence concerns the gene KRAS and lung cancer.